Issues & Trends

[Market In] HANWHA LIFE INSURANCE Partners with Centroid to Acquire Acuon Capital and Savings Bank

Hanwha Holds a Stake in Centroid First Joint Investment Since Acquiring a Stake Earlier This Year Outlook for Diversification of Comprehensive Financial Portfolios

Hur Jieun
2026-09-30 16:14:02
[Edaily Marketin Reporter Hur Jieun ] HANWHA LIFE INSURANCE(088350)is set to sign a Share Purchase Agreement (SPA) to acquire Acuon Capital. Centroid Investment, a private equity fund (PEF) manager in which HANWHA LIFE INSURANCE made an equity investment earlier this year, is expected to join as a financial investor (FI) and help secure funding for the acquisition.

According to investment banking (IB) industry sources on the 30th, HANWHA LIFE INSURANCE held a board meeting that day and approved the signing of an SPA to acquire the 96.06% stake in Accuon Capital held by EQT Partners. This comes about three months after HANWHA LIFE INSURANCE was selected as the preferred bidder for the acquisition last June. The deal structure also includes the acquisition of Accuon Savings Bank, in which Accuon Capital holds a 100% stake.

The acquisition price is reported to be less than 900 billion won. HANWHA LIFE INSURANCE will secure funding for this acquisition together with Centroid, which is considered a “related party.” Previously, in January, HANWHA LIFE INSURANCE acquired a 15% stake in Centroid, becoming its second-largest shareholder.

By acquiring both Acuon Capital and the savings bank, HANWHA LIFE INSURANCE is expected to move closer to diversifying its comprehensive financial portfolio. Adding a capital company and a savings bank to its existing insurance-centric business scope is likely to significantly broaden the group’s options for capital utilization.
In this transaction, Citigroup Global Markets Securities, UBS, and Sejong Law Firm served as advisors to the sellers. On the buyer’s side, Samjung KPMG and YulChon co., Ltd provided acquisition advisory services.

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

“The Era of 1.5 Million Robots”… The Korean Company JP Morgan Has Singled Out

A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…
2026-11-14 08:36:21